A key investor balks at buying IPO shares in Vascular Biogenics, voiding trading in the stock only six days after the biotech firm went public.
Alibaba may be the most anticipated IPO since Facebook, but underwriters may have to scramble to get institutional investors and mutual funds to buy…
Despite the conflict in Gaza, Israeli companies are raising capital and completing deals, although some employees have been called away on military…
Accounting tops the list among privately-held businesses, but sectors of health care and real estate have rebounded nicely and dominate the rankings.
Despite the government's highly accommodative monetary policy, interest rates charged on C&I loans are still above historical norms, says a new paper.
The COMPETE Act would permanently extend the R&D tax credit and help more small businesses qualify for it.
Warren Buffett’s massive cash pile could presage a string of future buyouts and investments — if the economy tanks.
Although a GAO study shows that big banks still have a funding edge over smaller rivals, it’s an advantage that has ebbed since the recession.
Is the government's initiative to help small suppliers a bag of wind or a bona fide hope?
Proponents of the virtual currency are dividing into two camps, one opposed to the rules and one in favor.